Why is hepatitis B still a global threat despite decades of vaccine availability? The answer lies in unequal access, evolving virus strains, and healthcare gaps. But a major shift is now underway—thanks to aggressive immunization drives, digital tracking, and biotech innovation, the fight against hepatitis B is regaining momentum. The Hepatitis B Vaccine Market is seeing renewed growth as...